{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-044154","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2023-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.636026+00:00","generated_at":"2026-06-10T16:22:40.298168+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Shareholders elect two Class II directors and ratify EY as auditor at 2023 AGM","bullets":["Daniel Gold elected as Class II director with 480,335,783 votes for, 189,651,604 withheld.","Meghan FitzGerald elected as Class II director with 668,955,006 votes for, 1,032,381 withheld.","Ratification of Ernst & Young as independent auditor for FY2024 passed with 709,944,901 for, 65,948 against, 253,423 abstain.","Total shares present at meeting: 710,264,272 out of 768,357,739 outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-044154","json":"https://secwatch.observer/filing/0001140361-23-044154.json","markdown":"https://secwatch.observer/filing/0001140361-23-044154.md","text":"https://secwatch.observer/filing/0001140361-23-044154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044154/0001140361-23-044154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044154/ef20010786_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T16:22:40.298168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b0404db7fb8874c5401d680bdfbe0669731c9975","claim":"Roivant Sciences Ltd. shareholders approved Election of Class II Directors at the 2023-09-12 meeting.","evidence_excerpt":"Shareholders elected the individuals named below to serve as Class II directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2026, and until their successors are duly elected and qualified, or until such director’s earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044154/0001140361-23-044154-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-09-12"}],"fact_type":"shareholder_vote"},{"claim_id":"cf3e3427f37fb17169aaae1e31708ed6dc537c85","claim":"Roivant Sciences Ltd. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm and as auditor for statutory purposes under the Bermuda Companies Act at the 2023-09-12 meeting.","evidence_excerpt":"Shareholders ratified the appointment of Ernst & Young LLP (“EY”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2024, and to appoint EY as the Company’s auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for the fiscal year ending March 31, 2024.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044154/0001140361-23-044154-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-09-12"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}